Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis
- PMID: 28736984
- DOI: 10.1111/vde.12467
Randomized, double-blinded, placebo-controlled pilot study on the effects of topical blackcurrant emulsion enriched in essential fatty acids, ceramides and 18-beta glycyrrhetinic acid on clinical signs and skin barrier function in dogs with atopic dermatitis
Abstract
Background: Lipid-based emulsions can be useful for the management of canine atopic dermatitis (cAD). 18-beta glycyrrhetinic acid (GRA), a component of liquorice root, has anti-inflammatory and anti-pruritic effects.
Hypothesis/objectives: To evaluate the effects of a topical lipid emulsion containing ceramides, fatty acids and GRA on clinical signs of cAD and skin barrier in a randomized, double-blinded, placebo-controlled trial.
Methods: Client owned (n = 45) dogs with nonseasonal, mild/moderate AD, received either treatment or placebo for three months. Skin lesions, pruritus, transepidermal water loss (TEWL) and global assessment (GA) were evaluated.
Results: Fourteen dogs receiving treatment and 14 receiving the placebo completed the study. After one month ≥50% reduction in pruritus was seen in seven of 14 dogs (50%) in the Treatment group, and in two of 14 dogs (14.3%) in the Control group (P = 0.047). After two and three months, significant reduction in pruritus was not seen. For Canine Atopic Dermatitis Extent and Severity Index (CADESI), TEWL and GA, there were no significant findings over time or between groups.
Conclusions and clinical relevance: The emulsion had some transient beneficial clinical effects. However, it was not effective in controlling pruritus as a monotherapy. Further studies should examine whether owner compliance was a factor in the steady decline of effect on pruritus scores. Further studies evaluating its role as an adjunctive therapy are indicated.
© 2017 ESVD and ACVD.
Similar articles
-
The effects of a topical lipid complex therapy on dogs with atopic dermatitis: a double blind, randomized, placebo-controlled study.Vet Dermatol. 2017 Aug;28(4):369-e84. doi: 10.1111/vde.12430. Epub 2017 Feb 20. Vet Dermatol. 2017. PMID: 28220545 Clinical Trial.
-
A blinded, randomized, placebo-controlled, dose determination trial of lokivetmab (ZTS-00103289), a caninized, anti-canine IL-31 monoclonal antibody in client owned dogs with atopic dermatitis.Vet Dermatol. 2016 Dec;27(6):478-e129. doi: 10.1111/vde.12376. Epub 2016 Sep 19. Vet Dermatol. 2016. PMID: 27647569 Clinical Trial.
-
The effect of a spot-on formulation containing polyunsaturated fatty acids and essential oils on dogs with atopic dermatitis.Vet J. 2014 Jan;199(1):39-43. doi: 10.1016/j.tvjl.2013.10.024. Epub 2013 Oct 29. Vet J. 2014. PMID: 24355814 Clinical Trial.
-
Interventions for atopic dermatitis in dogs: a systematic review of randomized controlled trials.Vet Dermatol. 2010 Feb;21(1):4-22. doi: 10.1111/j.1365-3164.2009.00784.x. Vet Dermatol. 2010. PMID: 20187910 Review.
-
The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective?Vet Immunol Immunopathol. 2001 Sep 20;81(3-4):347-62. doi: 10.1016/s0165-2427(01)00316-6. Vet Immunol Immunopathol. 2001. PMID: 11553397 Review.
Cited by
-
Skin Barrier Reinforcement Effect Assessment of a Spot-on Based on Natural Ingredients in a Dog Model of Tape Stripping.Vet Sci. 2022 Jul 28;9(8):390. doi: 10.3390/vetsci9080390. Vet Sci. 2022. PMID: 36006305 Free PMC article.
-
A moisturizer formulated with glycerol and propylene glycol accelerates the recovery of skin barrier function after experimental disruption in dogs.Vet Dermatol. 2020 Oct;31(5):344-e89. doi: 10.1111/vde.12859. Epub 2020 Jul 6. Vet Dermatol. 2020. PMID: 32628309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous